Tower Research Capital LLC (Trc) Bolt Biotherapeutics, Inc. Transaction History
Tower Research Capital LLC (Trc)
- $4.87 Billion
- Q4 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Bolt Biotherapeutics, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 4,008 shares of BOLT stock, worth $1,643. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,008
Previous 184
2078.26%
Holding current value
$1,643
Previous $0
Infinity%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding BOLT
# of Institutions
37Shares Held
18.3MCall Options Held
0Put Options Held
0-
Tang Capital Management LLC San Diego, CA3.81MShares$1.56 Million0.16% of portfolio
-
Vivo Capital, LLC Palo Alto, CA3.52MShares$1.44 Million0.38% of portfolio
-
Sofinnova Investments, Inc. Menlo Park, CA2.75MShares$1.13 Million0.12% of portfolio
-
Pivotal Bio Venture Partners Investment Advisor LLC San Francisco, CA1.89MShares$775,5010.96% of portfolio
-
Nan Fung Group Holdings LTD Central, K31.17MShares$478,4500.63% of portfolio
About Bolt Biotherapeutics, Inc.
- Ticker BOLT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 37,641,500
- Market Cap $15.4M
- Description
- Bolt Biotherapeutics, Inc., a clinical-stage biotechnology company, engages in the development of immuno-oncology agents to target tumor cells for elimination by the immune system. The company is developing BDC-1001, a human epidermal growth factor receptor 2 (HER2), which is in Phase I/II clinical trial for the treatment of patients with HER2-e...